Guidance on the use of coronary artery stents

  • Technology appraisal guidance
  • TA71
  • Published: 
  • Last updated: 
Download guidance (PDF)

9 Sources of evidence considered by the Committee

The following documentation and opinions were made available to the Committee:

The Assessment Report for this appraisal was prepared by Liverpool Reviews and Implementation Group, University of Liverpool.

  • Coronary artery stents: rapid systematic review and economic evaluation, February 2003

  • Assessment report – addendum A – data no longer confidential, June 2003

  • Assessment report – addendum B - further analysis requested by the Appraisal Committee, May 2003

The following organisations accepted the invitation to participate in this appraisal. They were invited to make submissions and comment on the draft scope, Assessment Report and the Appraisal Consultation Document (ACD). Consultee organisations are provided with the opportunity to appeal against the Final Appraisal Determination.

Companies or sponsors:

  • Abbott Vascular Devices Ltd

  • Bard Ltd

  • Biotronik UK Ltd

  • Boston Scientific Ltd

  • Cordis

  • Guidant Ltd

  • Jomed UK Ltd

  • Kimal

  • Medtronic Ltd

  • Sorin Biomedica UK Ltd

  • Terumo UK

  • WL Gore and Associates

Professional or specialist, and patient or carer groups:

  • Action Heart

  • Association of British Health-Care Industries

  • British Cardiac Industry Association

  • British Cardiovascular Intervention Society

  • British Cardiac Patients Association

  • British Cardiac Society

  • British Cardiovascular Industry Association

  • British Heart Foundation

  • Department of Health

  • EUCOMED

  • Heart UK

  • National Collaborating Centre for Chronic Conditions

  • NHS Quality Improvement Scotland

  • Royal College of Nursing

  • Royal College of Physicians

  • Southwark PCT and South East Public Health Network

  • Welsh Assembly Government

The following individuals were selected from clinical expert and patient advocate nominations from the professional or specialist and patient or carer groups. They participated in the Appraisal Committee discussions and provided evidence to inform the Appraisal Committee's deliberations. They gave their expert personal view on coronary artery stents by attending the initial Committee discussion and/or providing written evidence to the Committee. They were also invited to comment on the ACD.

  • Dr Mark de Belder, Assistant Secretary, British Cardiac Society and Consultant Cardiologist, The James Cook University Hospital, Middlesbrough

  • Dr Derek Connolly, Consultant Cardiologist, Heart UK and Sandwell and West Birmingham Hospitals NHS Trust AND Honorary Clinical Senior Lecturer, University of Birmingham

  • Dr A H Gershlick, Consultant Cardiologist, Department of Cardiology, Glenfield Hospital NHS Trust, Leicester

  • Mr S Livesey, Consultant Cardiac Surgeon, Southampton General Hospital

  • Professor M Rothman, Consultant Cardiologist, London Chest Hospital